| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 10 | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 2,321 |
| 809 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(R) | 1,219 | 51.3% | -1.09 | 571 | 70.6% |
| CRE(R) | 307 | 12.9% | -1.06 | 147 | 18.2% |
| PLP(R) | 387 | 16.3% | -7.60 | 2 | 0.2% |
| CentralBrain-unspecified | 248 | 10.4% | -1.89 | 67 | 8.3% |
| SCL(R) | 67 | 2.8% | -inf | 0 | 0.0% |
| SLP(R) | 43 | 1.8% | -5.43 | 1 | 0.1% |
| Optic-unspecified(R) | 44 | 1.9% | -inf | 0 | 0.0% |
| a'L(R) | 20 | 0.8% | -1.15 | 9 | 1.1% |
| PED(R) | 7 | 0.3% | -0.49 | 5 | 0.6% |
| LO(R) | 10 | 0.4% | -inf | 0 | 0.0% |
| b'L(R) | 5 | 0.2% | -0.32 | 4 | 0.5% |
| bL(R) | 5 | 0.2% | -0.74 | 3 | 0.4% |
| SIP(R) | 4 | 0.2% | -inf | 0 | 0.0% |
| ICL(R) | 4 | 0.2% | -inf | 0 | 0.0% |
| CA(R) | 3 | 0.1% | -inf | 0 | 0.0% |
| SMP(R) | 2 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCg-s1 | % In | CV |
|---|---|---|---|---|---|
| KCg-m (R) | 336 | DA | 563 | 25.0% | 0.6 |
| KCg-d (R) | 101 | DA | 425 | 18.9% | 0.7 |
| APL (R) | 1 | GABA | 196 | 8.7% | 0.0 |
| DPM (R) | 1 | DA | 133 | 5.9% | 0.0 |
| aMe12 (R) | 2 | ACh | 104 | 4.6% | 0.2 |
| PAM08 (R) | 16 | DA | 76 | 3.4% | 1.1 |
| MeVPLo2 (L) | 6 | ACh | 73 | 3.2% | 0.6 |
| aMe12 (L) | 4 | ACh | 60 | 2.7% | 0.2 |
| MeVPLo2 (R) | 7 | ACh | 46 | 2.0% | 0.5 |
| PAM08 (L) | 12 | DA | 38 | 1.7% | 0.7 |
| MBON05 (L) | 1 | Glu | 32 | 1.4% | 0.0 |
| PAM07 (R) | 7 | DA | 26 | 1.2% | 0.8 |
| PAM01 (R) | 9 | DA | 25 | 1.1% | 0.8 |
| aMe6a (R) | 1 | ACh | 24 | 1.1% | 0.0 |
| aMe26 (L) | 3 | ACh | 21 | 0.9% | 0.6 |
| KCg-s2 (R) | 1 | DA | 19 | 0.8% | 0.0 |
| MeVPMe4 (L) | 2 | Glu | 19 | 0.8% | 0.1 |
| LoVP37 (R) | 1 | Glu | 16 | 0.7% | 0.0 |
| CL063 (R) | 1 | GABA | 14 | 0.6% | 0.0 |
| aMe26 (R) | 3 | ACh | 14 | 0.6% | 0.3 |
| LoVP96 (R) | 1 | Glu | 13 | 0.6% | 0.0 |
| LoVP38 (R) | 2 | Glu | 12 | 0.5% | 0.3 |
| PAM12 (L) | 7 | DA | 12 | 0.5% | 0.4 |
| CB3676 (R) | 1 | Glu | 11 | 0.5% | 0.0 |
| MeVP43 (R) | 1 | ACh | 11 | 0.5% | 0.0 |
| PPL101 (L) | 1 | DA | 11 | 0.5% | 0.0 |
| PPL101 (R) | 1 | DA | 11 | 0.5% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 9 | 0.4% | 0.0 |
| KCg-s3 (R) | 1 | DA | 8 | 0.4% | 0.0 |
| PPL103 (R) | 1 | DA | 8 | 0.4% | 0.0 |
| aMe5 (R) | 3 | ACh | 8 | 0.4% | 0.5 |
| PLP231 (R) | 2 | ACh | 7 | 0.3% | 0.7 |
| MeVP5 (R) | 3 | ACh | 7 | 0.3% | 0.8 |
| KCa'b'-ap2 (R) | 6 | DA | 7 | 0.3% | 0.3 |
| PAM12 (R) | 6 | DA | 7 | 0.3% | 0.3 |
| OA-VPM3 (L) | 1 | OA | 6 | 0.3% | 0.0 |
| SLP098 (R) | 1 | Glu | 6 | 0.3% | 0.0 |
| SLP381 (R) | 1 | Glu | 6 | 0.3% | 0.0 |
| MeVP21 (R) | 2 | ACh | 6 | 0.3% | 0.3 |
| PAM07 (L) | 3 | DA | 6 | 0.3% | 0.4 |
| PAM01 (L) | 6 | DA | 6 | 0.3% | 0.0 |
| WEDPN12 (R) | 1 | Glu | 5 | 0.2% | 0.0 |
| MeVP41 (R) | 1 | ACh | 5 | 0.2% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 5 | 0.2% | 0.0 |
| KCab-p (R) | 4 | DA | 5 | 0.2% | 0.3 |
| MeVP12 (R) | 5 | ACh | 5 | 0.2% | 0.0 |
| CL364 (R) | 1 | Glu | 4 | 0.2% | 0.0 |
| PLP131 (R) | 1 | GABA | 4 | 0.2% | 0.0 |
| PPL103 (L) | 1 | DA | 4 | 0.2% | 0.0 |
| OA-VPM4 (L) | 1 | OA | 4 | 0.2% | 0.0 |
| MeVP20 (R) | 2 | Glu | 4 | 0.2% | 0.5 |
| PLP069 (R) | 2 | Glu | 4 | 0.2% | 0.5 |
| PLP089 (R) | 1 | GABA | 3 | 0.1% | 0.0 |
| AN09B033 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| LHPV6m1 (R) | 1 | Glu | 3 | 0.1% | 0.0 |
| GNG322 (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| LPT53 (R) | 1 | GABA | 3 | 0.1% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 3 | 0.1% | 0.0 |
| aMe30 (R) | 2 | Glu | 3 | 0.1% | 0.3 |
| OA-VUMa6 (M) | 2 | OA | 3 | 0.1% | 0.3 |
| VP2+_adPN (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| PPL104 (L) | 1 | DA | 2 | 0.1% | 0.0 |
| SLP360_c (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| CL291 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| PPL104 (R) | 1 | DA | 2 | 0.1% | 0.0 |
| PLP080 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| 5-HTPMPV01 (L) | 1 | 5-HT | 2 | 0.1% | 0.0 |
| aMe22 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| CSD (L) | 1 | 5-HT | 2 | 0.1% | 0.0 |
| MeVP32 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| CRE042 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| MBON01 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| KCa'b'-m (R) | 2 | DA | 2 | 0.1% | 0.0 |
| MeLo6 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| LT43 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| MBON35 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| PAM06 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| SLP242 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SLP295 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| PAM15 (R) | 1 | DA | 1 | 0.0% | 0.0 |
| CB2638 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP1 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| IB020 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CB2714 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| PLP042_c (R) | 1 | unc | 1 | 0.0% | 0.0 |
| PLP086 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| LC13 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LC28 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeLo3b (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE200m (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| SMP046 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP14 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe10 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP16 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| SLP460 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| LoVP43 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHPD1b1 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe23 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| CL315 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON09 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| CL282 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| SLP248 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| CL317 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| LoVP46 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| LoVP42 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP331 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP45 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CL064 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVC27 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| SLP230 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| 5thsLNv_LNd6 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| PPL102 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON20 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.0% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns KCg-s1 | % Out | CV |
|---|---|---|---|---|---|
| KCg-m (R) | 401 | DA | 777 | 28.0% | 0.7 |
| KCg-d (R) | 100 | DA | 464 | 16.7% | 0.8 |
| APL (R) | 1 | GABA | 213 | 7.7% | 0.0 |
| MBON09 (R) | 2 | GABA | 133 | 4.8% | 0.1 |
| MBON01 (R) | 1 | Glu | 113 | 4.1% | 0.0 |
| DPM (R) | 1 | DA | 106 | 3.8% | 0.0 |
| MBON05 (L) | 1 | Glu | 97 | 3.5% | 0.0 |
| PAM08 (R) | 21 | DA | 96 | 3.5% | 0.7 |
| MBON11 (R) | 1 | GABA | 80 | 2.9% | 0.0 |
| PAM01 (R) | 17 | DA | 72 | 2.6% | 0.9 |
| PAM07 (R) | 7 | DA | 63 | 2.3% | 0.7 |
| MBON30 (R) | 1 | Glu | 43 | 1.6% | 0.0 |
| PAM08 (L) | 19 | DA | 38 | 1.4% | 0.9 |
| MBON27 (R) | 1 | ACh | 37 | 1.3% | 0.0 |
| PPL101 (L) | 1 | DA | 29 | 1.0% | 0.0 |
| MBON32 (R) | 1 | GABA | 27 | 1.0% | 0.0 |
| PAM01 (L) | 13 | DA | 27 | 1.0% | 0.4 |
| KCg-s2 (R) | 1 | DA | 25 | 0.9% | 0.0 |
| PPL101 (R) | 1 | DA | 23 | 0.8% | 0.0 |
| MBON20 (R) | 1 | GABA | 23 | 0.8% | 0.0 |
| MBON21 (R) | 1 | ACh | 17 | 0.6% | 0.0 |
| MBON35 (R) | 1 | ACh | 17 | 0.6% | 0.0 |
| SMP376 (R) | 1 | Glu | 16 | 0.6% | 0.0 |
| MBON33 (R) | 1 | ACh | 15 | 0.5% | 0.0 |
| KCg-s3 (R) | 1 | DA | 13 | 0.5% | 0.0 |
| CRE048 (R) | 1 | Glu | 13 | 0.5% | 0.0 |
| PPL103 (L) | 1 | DA | 13 | 0.5% | 0.0 |
| OA-VPM4 (L) | 1 | OA | 11 | 0.4% | 0.0 |
| PAM12 (R) | 8 | DA | 11 | 0.4% | 0.4 |
| PAM07 (L) | 5 | DA | 10 | 0.4% | 0.6 |
| PPL103 (R) | 1 | DA | 9 | 0.3% | 0.0 |
| PAM12 (L) | 7 | DA | 9 | 0.3% | 0.4 |
| MBON16 (R) | 1 | ACh | 6 | 0.2% | 0.0 |
| MBON26 (R) | 1 | ACh | 6 | 0.2% | 0.0 |
| SMP165 (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| PAM15 (R) | 2 | DA | 5 | 0.2% | 0.2 |
| KCa'b'-ap2 (R) | 5 | DA | 5 | 0.2% | 0.0 |
| MBON04 (L) | 1 | Glu | 4 | 0.1% | 0.0 |
| LHPV9b1 (R) | 1 | Glu | 4 | 0.1% | 0.0 |
| MBON29 (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| SMP075 (R) | 1 | Glu | 3 | 0.1% | 0.0 |
| SMP114 (R) | 1 | Glu | 3 | 0.1% | 0.0 |
| SMP568_a (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| MBON28 (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| GNG322 (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| LHPV3c1 (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| CRE067 (R) | 2 | ACh | 3 | 0.1% | 0.3 |
| CRE200m (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| MBON10 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| SMP145 (R) | 1 | unc | 2 | 0.1% | 0.0 |
| MBON29 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 2 | 0.1% | 0.0 |
| PAM02 (R) | 1 | DA | 2 | 0.1% | 0.0 |
| MBON17 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| PPL104 (R) | 1 | DA | 2 | 0.1% | 0.0 |
| LAL159 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| AVLP563 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| PPL102 (L) | 1 | DA | 2 | 0.1% | 0.0 |
| CRE040 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| CRE037 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| FB1H (R) | 1 | DA | 1 | 0.0% | 0.0 |
| CRE022 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE008 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE075 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON04 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| FB1C (R) | 1 | DA | 1 | 0.0% | 0.0 |
| MBON12 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP157 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP049 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| LAL198 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| PAM06 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| MBON30 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| SMP714m (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CB2035 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| PAM05 (R) | 1 | DA | 1 | 0.0% | 0.0 |
| PAM15 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| MBON25-like (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE043_c1 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| KCg-s4 (R) | 1 | DA | 1 | 0.0% | 0.0 |
| CB2714 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE069 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| PLP042_c (R) | 1 | unc | 1 | 0.0% | 0.0 |
| CRE043_a3 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| SMP713m (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| IB017 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| AOTU022 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| CRE028 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE024 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE027 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE080_a (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| mAL6 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| aMe4 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| FB4O (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe26 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP152 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE022 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE042 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| aMe12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE080_c (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON22 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHCENT11 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHMB1 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON11 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| CRE023 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.0% | 0.0 |